| Vol. 7.08 – 14 March, 2022 |
| |
|
|
| Researchers demonstrated that PROCR-219Gly increased plasma levels of protein C through endothelial protein C receptor ectodomain shedding in endothelial cells, attenuating leukocyte-endothelial cell adhesion and vascular inflammation. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Based on proteomic profiling of angiogenic endothelial components, researchers reported βIV-spectrin, a non-erythrocytic cytoskeletal protein, as a critical regulator of sprouting angiogenesis. [Nature Communications] |
|
|
|
| Investigators demonstrated that secondary vascular field cells participated in vascular recovery after chemical ablation of vascular endothelial cells. [Developmental Cell] |
|
|
|
| Researchers investigated the role of RTN4/Nogo-A in mediating macroautophagy/autophagy and angiogenesis in the thalamus following middle cerebral artery occlusion. [Autophagy] |
|
|
|
| Scientists reported that cardiac stress-induced differential microRNA content, with miR-200c-3p being one of the most enriched, in cardiomyocyte-derived extracellular vesicles mediated functional crosstalk with endothelial cells. [Molecular Therapy] |
|
|
|
| In human pulmonary aortic endothelial cells,lipopolysaccharide-induced decreased in the amounts of endothelial nitric oxide synthase, thrombomodulin, and vascular endothelial–cadherin, which was blocked by treatment with UNC2250. [Science Signaling] |
|
|
|
| Macrophage-derived VEGF activated CD34+ progenitor cells within the adventitial vasculogenic zone to differentiate into CD31+ endothelial cells. [Cell Death & Disease] |
|
|
|
| Researchers investigated whether plasma Tie2 could predict response and progression cross-tumor for generic vascular endothelial growth factor inhibitors (VEGFi) treatment. [ESMO Open] |
|
|
|
| The authors investigated the role of histone deacetylase 11 (HDAC11) in vascular endothelial cell pyroptosis and its molecular mechanism. [Cell Death Discovery] |
|
|
|
| Scientists reported the identification of a novel adenosine monophosphate-activated protein kinase (AMPK) modulator, the indolic derivative IND6, which showed affinity for AMPKα1β1γ1, the primary AMPK isoform in human EA.Hy926 endothelial cells. [Scientific Reports] |
|
|
|
|
| The aim of this review is to summarize and provide an overview of the role of swiprosin-1 in pathophysiological conditions of cancers, cardiovascular diseases, diabetic nephropathy, neuropsychiatric diseases, and in the process of inflammation, immune response, and inflammatory diseases. [Life Sciences] |
|
|
|
|
| Samsung Bioepis Co., Ltd. and Biogen Canada Inc. announced that Health Canada has approved BYOOVIZ™ a biosimilar referencing LUCENTIS® for the treatment of neovascular age-related macular degeneration; visual impairment due to diabetic macular edema. [Samsung Bioepis Co., Ltd.] |
|
|
|
|
| March 20 – March 25, 2022 Vienna, Austria |
|
|
|
|
|
| Babraham Institute – Cambridgeshire, England, United Kingdom |
|
|
|
| Johns Hopkins School of Medicine – Saint Petersburg, Florida, United States |
|
|
|
| The University of Tennessee Health Science Center – Memphis, Tennessee, United States |
|
|
|
| Yale University – New Haven, Connecticut, United States |
|
|
|
| Columbia University – New York, New York, United States |
|
|
|
|